Abstract
Syntheses of (±)-cis-3-hydroxycarbonyl-7-(phenylacetamido)carbacephem (10), (±)-cis-3- methoxycarbonyl-7-(phenylacetamido)carbacephem (11), (±)-cis-2-chloro-3-hydroxycarbonyl-7-(phenylacetamido) carbacephem (14), and (±)-cis-2-chloro-3-methoxycarbonyl-7-(phenylacetamido)carbacephem (15) were accomplished. These four heretofore undescribed compounds 10, 11, 14, and 15 showed notable activity against Staphylococcus aureus FDA 209P, Escherichia coli ATCC 39188, Pseudomonas aeruginosa 1101-75, Klebsiella pneumoniae NCTC 418 as well as the β-lactamase producing organisms E. coli A9675, P. aeruginosa 18S-H and methicillin-resistant organism S. aureus 95. The electronic activation of lactam moieties of 11 and 15 enhanced remarkably their antibacterial activity relative to those of the 10 and 14. The chlorine atom in 14 and 15, acting as an effective leaving group, also resulted in an increment in the biological activity in comparison with those of the parent carbacephemes 10 and 11. The mode of action related to 14 and 15 can be explained by a non-classical [1,4]-elimination process.
Keywords: Cephalosporin, carbacephem, b-Lactam, b-Lactamase, antibiotic, antibacterial
Letters in Drug Design & Discovery
Title: Design, Synthesis, and Antibacterial Activity of Novel Carbacephems
Volume: 3 Issue: 2
Author(s): Ali A. Moosavi-Movahedi, Chi-Feng Yen, Jamshid Chamani, Ghadam A. Khodarahmi, Ali A. Saboury and Gholam H. Hakimelahi
Affiliation:
Keywords: Cephalosporin, carbacephem, b-Lactam, b-Lactamase, antibiotic, antibacterial
Abstract: Syntheses of (±)-cis-3-hydroxycarbonyl-7-(phenylacetamido)carbacephem (10), (±)-cis-3- methoxycarbonyl-7-(phenylacetamido)carbacephem (11), (±)-cis-2-chloro-3-hydroxycarbonyl-7-(phenylacetamido) carbacephem (14), and (±)-cis-2-chloro-3-methoxycarbonyl-7-(phenylacetamido)carbacephem (15) were accomplished. These four heretofore undescribed compounds 10, 11, 14, and 15 showed notable activity against Staphylococcus aureus FDA 209P, Escherichia coli ATCC 39188, Pseudomonas aeruginosa 1101-75, Klebsiella pneumoniae NCTC 418 as well as the β-lactamase producing organisms E. coli A9675, P. aeruginosa 18S-H and methicillin-resistant organism S. aureus 95. The electronic activation of lactam moieties of 11 and 15 enhanced remarkably their antibacterial activity relative to those of the 10 and 14. The chlorine atom in 14 and 15, acting as an effective leaving group, also resulted in an increment in the biological activity in comparison with those of the parent carbacephemes 10 and 11. The mode of action related to 14 and 15 can be explained by a non-classical [1,4]-elimination process.
Export Options
About this article
Cite this article as:
Moosavi-Movahedi A. Ali, Yen Chi-Feng, Chamani Jamshid, Khodarahmi A. Ghadam, Saboury A. Ali and Hakimelahi H. Gholam, Design, Synthesis, and Antibacterial Activity of Novel Carbacephems, Letters in Drug Design & Discovery 2006; 3 (2) . https://dx.doi.org/10.2174/157018006775789766
DOI https://dx.doi.org/10.2174/157018006775789766 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Effects of Natural Products on Contact Dermatitis
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents The Role of Inspiratory Pressures in Determining the Flow Rates Though Dry Powder Inhalers; A Review
Current Pharmaceutical Design Paving Roads for New Drugs in Oncology
Recent Patents on Anti-Cancer Drug Discovery Beta-Blockers: Current State of Knowledge and Perspectives
Mini-Reviews in Medicinal Chemistry Histamine-Dependent and -Independent Hypersensitivity Reactions to Contrast Media: The Impact of Antihistamines
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry What we have Learned from Animal Models of Mycoplasma pneumoniae Disease: Virulence Mechanisms and Host Responses
Current Pediatric Reviews Sirtuin-1 and HIV-1: An Overview
Current Drug Targets Exploring Modifications in Fetal Telomere Programming in Mothers Exposed to Multiple Risk Factors
Current Women`s Health Reviews In Vitro Effects of Nickel on Healthy Non-Allergic Peripheral Blood Mononuclear Cells. The Role of Red Grape Polyphenols
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Trypanosoma cruzi Platelet-activating Factor Receptors: Scope for the Development of Novel Drugs to Treat Chagas Disease
Mini-Reviews in Medicinal Chemistry Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology The Myometrium in Pregnant Women with Obesity
Current Vascular Pharmacology Regulation of Inflammation: A Review of Recent Advances in Anti- Inflammatory Strategies
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Drug Delivery Systems for the Treatment of Diabetes Mellitus: State of the Art
Current Pharmaceutical Design TRPM8, a Sensor for Mild Cooling in Mammalian Sensory Nerve Endings
Current Pharmaceutical Biotechnology Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses
Mini-Reviews in Medicinal Chemistry Idiopathic Pulmonary Fibrosis: An EU Patient Perspective Survey
Current Respiratory Medicine Reviews Mechanisms at the Interface of Innate and Adaptive Immunity in the Pathogenesis of RSV Disease: Lessons from the Mouse Model
Current Respiratory Medicine Reviews Pulmonary Pathology Among Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis
Current Diabetes Reviews Targeting Cytokines as an Approach to Modulate Allergic Diseases: The Clinical Experience
Medicinal Chemistry Reviews - Online (Discontinued)